Celldex Therapeutics Inc (CLDX)

Dec 09, 2025

Celldex Therapeutics Initiates Global Phase 3 Trial for Barzolvolimab in Cold Urticaria, Symptomatic Dermographism - marketscreener.com

Dec 09, 2025

Dec 09, 2025

Celldex initiates phase 3 trial for cold urticaria and dermographism drug - Investing.com Canada

Dec 09, 2025

Dec 09, 2025

Celldex Initiates Global Registrational Phase 3 Program Of Barzolvolimab In Cold Urticaria And Symptomatic Dermographism - TradingView

Dec 09, 2025

Dec 09, 2025

Celldex Initiates Global Registrational Phase 3 Program of - GlobeNewswire

Dec 09, 2025

Dec 09, 2025

19,627 Shares in Celldex Therapeutics, Inc. $CLDX Purchased by Bollard Group LLC - Defense World

Dec 09, 2025

Dec 08, 2025

Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - The Manila Times

Dec 08, 2025

Dec 05, 2025

Celldex Therapeutics (NASDAQ:CLDX) Reaches New 12-Month HighHere's Why - MarketBeat

Dec 05, 2025

Dec 05, 2025

Does Celldex Therapeutics Inc (CLDX) offer a good opportunity for investors? - Setenews

Dec 05, 2025

Dec 05, 2025

Celldex Therapeutics stock hits 52-week high at $29.14 By Investing.com - Investing.com Nigeria

Dec 05, 2025

Dec 05, 2025

How Celldex Therapeutics Inc. (TCE2) stock stacks up against competitorsJuly 2025 Levels & Stepwise Entry and Exit Trade Signals - Newser

Dec 05, 2025

Dec 04, 2025

Can Celldex Therapeutics Inc. (TCE2) stock sustain institutional flowsInflation Watch & Consistent Return Investment Signals - Newser

Dec 04, 2025

Dec 04, 2025

Celldex Therapeutics stock hits 52-week high at $29.14 - Investing.com

Dec 04, 2025

Dec 04, 2025

Fisher Asset Management LLC Sells 49,420 Shares of Celldex Therapeutics, Inc. $CLDX - Defense World

Dec 04, 2025

Dec 04, 2025

American Century Companies Inc. Grows Position in Celldex Therapeutics, Inc. $CLDX - Defense World

Dec 04, 2025

Dec 03, 2025

Can Celldex Therapeutics Inc. (TCE2) stock sustain revenue momentumPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - Newser

Dec 03, 2025

Dec 03, 2025

Is Celldex Therapeutics Inc. (TCE2) stock testing key supportWeekly Trend Summary & Safe Capital Growth Plans - Newser

Dec 03, 2025

Dec 03, 2025

Will Celldex Therapeutics Inc. stock outperform international peersWeekly Risk Report & Stepwise Entry/Exit Trade Alerts - Newser

Dec 03, 2025

Dec 02, 2025

Imvax Gets Positive Overall Survival Data From Phase IIb GBM Asset - Citeline News & Insights

Dec 02, 2025

Dec 02, 2025

Why Celldex Therapeutics Inc. (TCE2) stock gets analyst attention2025 Key Lessons & Expert Approved Momentum Trade Ideas - Newser

Dec 02, 2025

Dec 02, 2025

Why Celldex Therapeutics Inc. (TCE2) stock is listed among top recommendationsWeekly Risk Summary & Long-Term Capital Growth Ideas - Newser

Dec 02, 2025

Dec 02, 2025

Is Celldex Therapeutics Inc. (TCE2) stock a buy during volatile marketsJuly 2025 EndofMonth & Fast Momentum Entry Tips - Newser

Dec 02, 2025

Dec 01, 2025

Evercore Healthcare Conference - marketscreener.com

Dec 01, 2025

Nov 28, 2025

Geode Capital Management LLC Has $34.05 Million Stake in Celldex Therapeutics, Inc. $CLDX - MarketBeat

Nov 28, 2025

Nov 27, 2025

Block Trades: Is Celldex Therapeutics Inc. stock supported by innovation pipelineMarket Trend Review & Short-Term Trading Opportunity Alerts - moha.gov.vn

Nov 27, 2025

Nov 27, 2025

Precision Trading with Celldex Therapeutics Inc. (CLDX) Risk Zones - news.stocktradersdaily.com

Nov 27, 2025

Nov 25, 2025

Segall Bryant & Hamill LLC Invests $7.89 Million in Celldex Therapeutics, Inc. $CLDX - MarketBeat

Nov 25, 2025

Nov 24, 2025

Celldex Therapeutics Hits Day High with Strong 7.72% Intraday Surge - Markets Mojo

Nov 24, 2025

Nov 21, 2025

Eczema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution - The Globe and Mail

Nov 21, 2025

Nov 21, 2025

How Investors May Respond To Celldex Therapeutics (CLDX) Leadership Change and Widening Third-Quarter Losses - Sahm

Nov 21, 2025

Nov 21, 2025

A look into Celldex Therapeutics Inc (CLDX)’s deeper side - Setenews

Nov 21, 2025

Nov 21, 2025

Will Celldex Therapeutics Inc. (TCE2) stock see insider accumulationDip Buying & Reliable Entry Point Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Can Celldex Therapeutics Inc. (TCE2) stock reach $200 price targetGDP Growth & Verified Trade Idea Suggestions - newser.com

Nov 21, 2025

Nov 21, 2025

Why Celldex Therapeutics Inc. stock could be next big winnerRisk Management & Reliable Entry Point Trade Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Real time social sentiment graph for Celldex Therapeutics Inc.2025 Key Lessons & High Accuracy Investment Signals - newser.com

Nov 21, 2025

Nov 20, 2025

Celldex Therapeutics Hits Day High with 9.61% Surge in Stock Price - Markets Mojo

Nov 20, 2025

Nov 20, 2025

What risks investors should watch in Celldex Therapeutics Inc. stockWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com

Nov 20, 2025

Nov 20, 2025

Celldex Therapeutics, Inc. $CLDX Shares Bought by TSP Capital Management Group LLC - MarketBeat

Nov 20, 2025

Nov 20, 2025

Celldex Therapeutics Inc. stock momentum explained2025 Sector Review & Low Risk High Reward Ideas - newser.com

Nov 20, 2025

Nov 19, 2025

Does Celldex Therapeutics Inc. qualify in momentum factor screening - newser.com

Nov 19, 2025

Nov 19, 2025

How to use a screener to detect Celldex Therapeutics Inc. breakoutsTrade Signal Summary & Free Safe Capital Growth Stock Tips - newser.com

Nov 19, 2025

Nov 19, 2025

What’s next for Celldex Therapeutics Inc. stock price2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com

Nov 19, 2025

Nov 19, 2025

What momentum shifts mean for Celldex Therapeutics Inc.2025 Institutional Moves & Safe Swing Trade Setup Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Celldex Therapeutics (CLDX): Assessing Valuation After Recent Revenue Growth and Share Price Swings - Sahm

Nov 19, 2025

Nov 19, 2025

Is Celldex Therapeutics Inc. stock a bargain at current levelsMarket Activity Recap & Weekly High Conviction Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Visualizing Celldex Therapeutics Inc. stock with heatmapsAnalyst Upgrade & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 19, 2025